In a world chasing AI and biotech unicorns, RanD operates in the shadows of surgical oncology with a ruthlessly focused playbook. They don't build general medical devices; they build the machines that keep surgeons alive and patients hopeful.

"Their domain authority is weak, but their clinical authority is absolute. In surgical oncology, the latter matters more."

The keyword data reveals a fascinating disconnect. Their top organic keyword is simply 'rand' with 28K monthly searches—likely brand confusion with RAND Corporation, the policy think tank. Yet their actual surgical keywords like 'maquina medidora креатинкиназа' and 'psogı' suggest they're targeting specific medical procedures in niche international markets, likely Spanish and Eastern European regions where they have no direct brand presence.

• Revenue-per-employee ratio indicates premium surgical equipment pricing
• 43% organic traffic suggests strong clinical word-of-mouth referral
• Social presence spans Twitter, Facebook, LinkedIn, and Instagram—unusual for a B2B medical device company
• Tech stack includes Zendesk, indicating active customer support infrastructure